Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide is an investigational once-weekly injectable medication that activates three hormone receptors (GLP-1, GIP, and glucagon) to promote weight loss
If you have accessed retatrutide outside a clinical trial, you should report any suspected side effects via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
Track your weekly results for weight loss trends
Expanding access and affordability of treatment One of the strongest arguments for virtual prescribing is the increased access to life-changing medications
While filling one GLP-1 prescription may be cheaper in the short term, if you plan to maintain results, you must account for staying on these medications for life
Tkaczenko H, Kurhaluk N
US$ 27.45
US$ 21.94
US$ 28.09
US$ 28.62
US$ 28.71
US$ 26.46
